Tim Demuth
Chief Tech/Sci/R&D Officer at MORPHOSYS AG
Profile
Tim Demuth is currently the Chief Research & Development Officer at MorphoSys AG since 2022.
Prior to this, he was the Chief Medical Officer & Senior Vice President at Pieris Pharmaceuticals, Inc. from 2021 to 2022.
He also held positions as VP & Head-Global Clinical Development Oncology at Merck KGaA and Head-Clinical Development at Sandoz AG.
Dr. Demuth obtained a doctorate degree from The Johannes Gutenberg University of Mainz.
Tim Demuth active positions
Companies | Position | Start |
---|---|---|
MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 2022-09-30 |
Former positions of Tim Demuth
Companies | Position | End |
---|---|---|
PIERIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-09-29 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
MERCK KGAA | Corporate Officer/Principal | - |
Training of Tim Demuth
The Johannes Gutenberg University of Mainz | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
MERCK KGAA | Health Technology |
MORPHOSYS AG | Health Technology |
PIERIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Tim Demuth